GlassScriptPhysician profile
Mitchel Wong
NPI 1659379204
$1,757.68
in general payments reported to CMS, 2019-2025
14 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $98.94 · 2021: $115 · 2022: $124 · 2023: $149 · 2024: $200 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $673.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $362.12 | 2019 | |
| New World Medical,INC. | $199.65 | 2024 | Ahmed Glaucoma Valve, Clearpath, Kahook Dual Blade |
| Alcon Vision LLC | $172.75 | 2025 | Centurion, Tryptyr |
| Sight Sciences, INC. | $126.54 | 2025 | Omni Surgical System |
| Abbvie INC. | $125.92 | 2019-2021 | |
| Horizon Therapeutics Plc | $124.40 | 2022 | |
| Apellis Pharmaceuticals, INC. | $119.32 | 2023 | |
| Mallinckrodt Enterprises LLC | $119.31 | 2019 | |
| Allergan, INC. | $114.46 | 2019 | |
| Biotissue Holdings INC. | $98.94 | 2020 | |
| Optos, INC. | $98.66 | 2021 | |
| Novartis Pharmaceuticals Corporation | $40.66 | 2019 | |
| Ironshore Pharmaceuticals INC. | $29.55 | 2023 | Jornay Pm |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $25.40 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchel Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.